Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.
Youssef, H., Ibrahim, R., Hassan, M., Muhammad, M., El-talees, A. (2022). Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.. EKB Journal Management System, 39(Special issue (Academic)), 266-276. doi: 10.21608/bmfj.2022.141060.1598
Heba Youssef; Reham Ibrahim; Mahmoud Mostafa Hassan; Marwa Hassan Muhammad; Alaa El-Deen El-talees. "Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.". EKB Journal Management System, 39, Special issue (Academic), 2022, 266-276. doi: 10.21608/bmfj.2022.141060.1598
Youssef, H., Ibrahim, R., Hassan, M., Muhammad, M., El-talees, A. (2022). 'Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.', EKB Journal Management System, 39(Special issue (Academic)), pp. 266-276. doi: 10.21608/bmfj.2022.141060.1598
Youssef, H., Ibrahim, R., Hassan, M., Muhammad, M., El-talees, A. Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.. EKB Journal Management System, 2022; 39(Special issue (Academic)): 266-276. doi: 10.21608/bmfj.2022.141060.1598

Targeting PPARγ/ Irisin pathway in the potential effect of metformin on D-galactose-induced hepatic aging in rats.

Benha Medical Journal
Article 283, Volume 39, Special issue (Academic), September and October 2022, Page 266-276  XML PDF (821.17 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2022.141060.1598
View on SCiNiTO View on SCiNiTO
Authors
Heba Youssef email 1; Reham Ibrahimorcid 2; Mahmoud Mostafa Hassan3; Marwa Hassan Muhammad4; Alaa El-Deen El-talees1
1Physiology department, Benha faculty of medicine
2Physiology department, Faculty of medicine, Benha university
3department of physiology faculty of medecine Benha university
4Physiology Department-Faculty of Medicine-Benha University
Abstract
Background: Aging-related changes in liver alter both hepatic structure and function thus, increasing the mortality rate in susceptible old patients. Metformin provide health benefits to elderly individuals when ingested in appropriate amounts and it is one of the physiological triggers of Peroxisome Proliferator- Activated Receptor- Gamma (PPARγ) and irisin Aim: This study aimed to investigate the effect of metformin on hepatic aging induced by D- galactose (D- gal) in rats clarifying the role of PPARγ/ irisin pathway in this process. Methods: 24 adult Wister albino male rats divided into 4 groups: group I (control group): rats received saline; ip, group II (D- gal group): rats received D- gal; ip, group III (Metformin group): rats received Metformin orally & group IV(Metformin + D- gal group): rats received D- gal with Metformin.
At the end of expriment, The serum samples were taken for biochemical estimation of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Albumin and hepatic PPARγ and irisin protein levels Results: compared to control group, D- gal caused hepatic injury confirmed by a significant increase in ALT and AST with a significant decrease in Albumin. Metformin in group IV prevented these changes through increased hepatic PPARγ and irisin. Conclusion: Metformin showed a protective effect against the D- gal induced hepatic aging through induction of hepatic PPARγ and irisin.
Keywords
hepatic aging; D- gal; Metformin; PPARγ; irisin
Statistics
Article View: 206
PDF Download: 228